_version_ 1818837492961378304
author Frank Riemer
Pippa G Corrie
Catherine Booth
Ferdia A Gallagher
Kevin M Brindle
Martin J Graves
Arthur Lewis
Doreen Lau
Mary A McLean
Andrew N Priest
Andrew B Gill
Francis Scott
Ilse Patterson
Bruno Carmo
Joshua D Kaggie
Amy Frary
Doreen Milne
Michal Sulikowski
Lee Brown
Jean-Martin Lapointe
Luigi Aloj
author_facet Frank Riemer
Pippa G Corrie
Catherine Booth
Ferdia A Gallagher
Kevin M Brindle
Martin J Graves
Arthur Lewis
Doreen Lau
Mary A McLean
Andrew N Priest
Andrew B Gill
Francis Scott
Ilse Patterson
Bruno Carmo
Joshua D Kaggie
Amy Frary
Doreen Milne
Michal Sulikowski
Lee Brown
Jean-Martin Lapointe
Luigi Aloj
author_sort Frank Riemer
collection DOAJ
first_indexed 2024-12-19T03:23:22Z
format Article
id doaj.art-dcf7672568004450b3bd5e066f9c38eb
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-12-19T03:23:22Z
publishDate 2021-09-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-dcf7672568004450b3bd5e066f9c38eb2022-12-21T20:37:43ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-09-019910.1136/jitc-2021-003125Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanomaFrank Riemer0Pippa G Corrie1Catherine Booth2Ferdia A Gallagher3Kevin M Brindle4Martin J Graves5Arthur Lewis6Doreen Lau7Mary A McLean8Andrew N Priest9Andrew B Gill10Francis Scott11Ilse Patterson12Bruno Carmo13Joshua D Kaggie14Amy Frary15Doreen Milne16Michal Sulikowski17Lee Brown18Jean-Martin Lapointe19Luigi Aloj201 Department of Radiology, University of Cambridge, Cambridge, UK4 Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke`s Hospital, Cambridge, UK4 Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke`s Hospital, Cambridge, UK1 Department of Radiology, University of Cambridge, Cambridge, UK7 Cancer Research UK Cambridge Research Institute, Cambridge, UK1 Department of Radiology, University of Cambridge, Cambridge, UK5 Clinical Pharmacology & Safety Sciences, AstraZeneca PLC, Cambridge, Cambridgeshire, UK1 Department of Radiology, University of Cambridge, Cambridge, UK1 Department of Radiology, University of Cambridge, Cambridge, UK1 Department of Radiology, University of Cambridge, Cambridge, UK1 Department of Radiology, University of Cambridge, Cambridge, UK1 Department of Radiology, University of Cambridge, Cambridge, UK3 Department of Radiology, Addenbrooke`s Hospital, Cambridge, UK3 Department of Radiology, Addenbrooke`s Hospital, Cambridge, UK1 Department of Radiology, University of Cambridge, Cambridge, UK1 Department of Radiology, University of Cambridge, Cambridge, UK4 Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke`s Hospital, Cambridge, UK5 Clinical Pharmacology & Safety Sciences, AstraZeneca PLC, Cambridge, Cambridgeshire, UK5 Clinical Pharmacology & Safety Sciences, AstraZeneca PLC, Cambridge, Cambridgeshire, UK5 Clinical Pharmacology & Safety Sciences, AstraZeneca PLC, Cambridge, Cambridgeshire, UK1 Department of Radiology, University of Cambridge, Cambridge, UKhttps://jitc.bmj.com/content/9/9/e003125.full
spellingShingle Frank Riemer
Pippa G Corrie
Catherine Booth
Ferdia A Gallagher
Kevin M Brindle
Martin J Graves
Arthur Lewis
Doreen Lau
Mary A McLean
Andrew N Priest
Andrew B Gill
Francis Scott
Ilse Patterson
Bruno Carmo
Joshua D Kaggie
Amy Frary
Doreen Milne
Michal Sulikowski
Lee Brown
Jean-Martin Lapointe
Luigi Aloj
Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
Journal for ImmunoTherapy of Cancer
title Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
title_full Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
title_fullStr Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
title_full_unstemmed Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
title_short Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
title_sort multiparametric mri of early tumor response to immune checkpoint blockade in metastatic melanoma
url https://jitc.bmj.com/content/9/9/e003125.full
work_keys_str_mv AT frankriemer multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT pippagcorrie multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT catherinebooth multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT ferdiaagallagher multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT kevinmbrindle multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT martinjgraves multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT arthurlewis multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT doreenlau multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT maryamclean multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT andrewnpriest multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT andrewbgill multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT francisscott multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT ilsepatterson multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT brunocarmo multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT joshuadkaggie multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT amyfrary multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT doreenmilne multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT michalsulikowski multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT leebrown multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT jeanmartinlapointe multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma
AT luigialoj multiparametricmriofearlytumorresponsetoimmunecheckpointblockadeinmetastaticmelanoma